Stocks Celgene Corp

  • With Amgen dropping after hours and Merck, Celgene and others reporting earnings on Thursday, how should you game health care?

  • MM_promo_Cramerica_Challenge_530x50.jpg

    Cramer makes the call on viewers' favorite stocks.

  • MM_promo_Cramerica_Challenge_530x50.jpg

    Cramer makes the call on viewers' favorite stocks.

  • Biotech companies continued their rally today, with the biotech index up more than 35 percent in the last three months. Eric Schmidt, biotech analyst at Cowen, and Joel Sendek, managing director and biotech analyst at Lazard Capital Markets, explained the force behind the comeback and the best stock plays for investors right now.

  • Stocks hit new highs for 2009 after the weak dollar sent oil, gold and other commodities sharply higher.

  • The drive for Dow 10,000 hit a bump in the road Monday as investors took a breather, sending stocks down more than half a percent at the open. Stocks remained lower after a report showed leading indicators rose for a fifth straight month.

  • Plus, Cramer makes the call on Obama's health-care plans, smartphone data overload and more.

  • The drive for Dow 10,000 hit a bump in the road Monday as investors took a breather, sending stocks down more than half a percent at the open. Stocks remained lower after a report showed leading indicators rose for a fifth straight month.

  • cadeuses2.jpg

    Today is the 16th annual "Newsmakers in Biotech" event put on by Thomson Reuters and BioCentury.

  • google_headquarters_htease.jpg

    Investors were going gaga for Google (GOOG) five years ago today. In one of the most anticipated IPOs over the past decade, the Internet search company priced nearly 20 million shares at $85 per share, raising $1.7 billion dollars through an auction of its shares.

  • Fortune

    For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • There’s no offense like a good defense. Find out how to keep your cash, even in the worst of times.

  • Technology and financial stocks have had their run since the beginning of this market rally so don’t expect to see a strong upward trend to continue going forward, said Jerry Jordan, portfolio manager at Jordan Opportunity Fund. He shared his investment strategy with investors.

  • Pharma Stocks

    Everyone’s talking about the July stock market rally. And, of course, you can’t overlook the outperformance of biotech—big and small.

  • Cramer makes the call on viewers' favorite stocks.

  • Cramer makes the call on viewers' favorite stocks.

  • Plus, get calls on China, pharma, the industrials and more.

  • cadeuses2.jpg

    What a week! And there's still one day left. Human Genome Sciences and Orexigen got the party started on Monday with their Lupus and diet drug data, respectively. Onyx Pharmaceuticals was a surprise guest with its mid-stage breast cancer results on Wednesday. Bristol-Myers Squibb cranked up the volume late yesterday with its two-bagger for Medarex. And then this morning Celgene announced it had stopped a multiple myeloma study early because the drug appears to be working so well.

  • Find out why Cramer says this is a bad move. Plus, get calls on retail, biotech, the housing bottom and more.